← Open Payments lookup

KELLY CRAWFORD: Open Payments

NPI 1225558588 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,415 in 160 payments from 22 companies in 2025. Trend: 2023 $2,397 · 2024 $2,663 · 2025 $2,415

Food & beverage: $2,415
CompanyPaymentsAmount
ABBVIE INC.48$557
Salix Pharmaceuticals, a division of Bausch Health US, LLC22$277
Aimmune Therapeutics, Inc.9$174
GENZYME CORPORATION8$163
Janssen Biotech, Inc.10$162
Ardelyx, Inc.11$154
Phathom Pharmaceuticals, Inc.9$119
Regeneron Healthcare Solutions, Inc.5$107
Lilly USA, LLC6$100
Takeda Pharmaceuticals U.S.A., Inc.5$93

Products named: XIFAXAN, DUPIXENT, TREMFYA, RINVOQ, IBSRELA, MAVYRET, VOQUEZNA, OMVOH.

Industry payments across SC — which companies pay providers there.